Brioschi Effervescent Antacid
NDC Package 69276-200-05
Package Information
Brioschi Effervescent Antacid is fully dissolve 5 grams (1 packet) in a 4-6 ounces of water before drinking • do not use more than directedAdults and children 12 years and olderAdults 60 years and olderChildren under 12One dose (1 packet) each hourOne dose (1 packet) each hourAsk a doctorDo not exceed 4 doses in 24 hoursDo not exceed 4 doses in 24 hours. Marketed by Neobourne Pharma Lp, this product is identified by NDC 69276-200 and is authorized under FDA application part331.
Identification & Billing
- RxCUI: 1656654 - sodium bicarbonate 1.02 GM per 5 GM Granules for Oral Solution
- RxCUI: 1656654 - sodium bicarbonate 1020 MG Granules for Oral Solution
- RxCUI: 1656654 - NaHCO3 1020 MG Granules for Oral Solution
- RxCUI: 1656660 - Brioschi 1.02 GM Granule for Oral Solution
- RxCUI: 1656660 - sodium bicarbonate 1020 MG Granules for Oral Solution [Brioschi Antacid]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69276 - Neobourne Pharma Lp
- 69276-200 - Brioschi Effervescent Antacid
- 69276-200-05 - 10 PACKET in 1 CARTON / 5 g in 1 PACKET
- 69276-200 - Brioschi Effervescent Antacid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69276-200). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69276-200-05 identifies a specific commercial package of 10 packet in 1 carton / 5 g in 1 packet of Brioschi Effervescent Antacid, labeled by Neobourne Pharma Lp. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neobourne Pharma Lp on June 30, 2015. The current certification is valid through February 04, 2016.
How is this Neobourne Pharma Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69276020005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
